References

1) Molteno AC, Bevin TH, Herbison P, Husni MA. Long-term results of primary trabeculectomies and Molteno implants for primary open-angle glaucoma. Arch Ophthalmol. 2011 Nov;129(11):1444-50.

2) Thompson AM, Molteno AC, Bevin TH, Herbison P. Otago glaucoma surgery outcome study: comparative results for the 175-mm2 Molteno3 and double-plate Molteno implants. JAMA Ophthalmol. 2013 Feb;131(2):155-9.

3) Molteno AC, Sayawat N, Herbison P. Otago glaucoma surgery outcome study: long-term results of uveitis with secondary glaucoma drained by Molteno implants. Ophthalmology. 2001;108(3):605-13.

4) Molteno AC, Bevin TH, Herbison P, Houliston M. Otago glaucoma surgery outcome study: long-term follow-up of cases of primary glaucoma with additional risk factors drained by Molteno implants. Ophthalmology. 2001;108(12):2193-200.

5) Valimaki JO, Ylilehto AP. Molteno3 implantation as primary glaucoma surgery. J Ophthalmol. 2014;2014:167564.

6) Valimaki J. Surgical management of glaucoma with Molteno3 implant. J Glaucoma. 2012 Jan;21(1):7-11.

7) Freedman J, Bhandari R. Supra-Tenon capsule placement of original Molteno vs Molteno 3 tube implants in black patients with refractory glaucoma: a single-surgeon experience. Arch Ophthalmol. 2011 Aug;129(8):993-7.

8) Patel SR, Silverman A, Patel S, Reiss G. Comparison of surgical outcomes of the Molteno 185mm2 shunt and the Molteno 245mm2 shunt: is there a difference? Unpublished data related to poster (reference 14) presented at the annual meeting of the American Glaucoma Society, Coronado, California. February 2015.

9) Choritz L, Koynov K, Renieri G, Barton K, Pfeiffer N, Thieme H. Surface topographies of glaucoma drainage devices and their influence on human tenon fibroblast adhesion. Invest Ophthalmol Vis Sci. 2010;51(8):4047-53.

10) Jordan DR, Hwang I, Brownstein S, McEachren T, Gilberg S, Grahovac S, et al. The Molteno M-Sphere. Ophthal Plast Reconstr Surg. 2000 Sep;16(5):356-62.

11) Molteno AC, Elder MJ. Bone implants after enucleation. Aust N Z J Ophthalmol. 1991 May;19(2):129-36.

12) Hong C, Arosemena A, Zurakowski D, Ayyala RS. Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol. 2005;50(1):48-60.

13) Molteno A, Polkinghorne P, Bowbyes J. The vicryl tie technique for inserting a draining implant in the treatment of secondary glaucoma. Aust N Z J Ophthalmol. 1986;14(4):343-54.

14) Patel SR, Silverman AL, Patel SS, Reiss GR. Comparison of surgical outcomes of the Molteno 185 mm2 and the Baerveldt 250 mm2: is there a difference? 25th Annual Meeting of the American Glaucoma Society (AGS), Coronado, California. February 27, 2015.

15) Suter AJ, Molteno AC, Bevin TH, Fulton JD, Herbison P. Long term follow up of bone derived hydroxyapatite orbital implants. Br J Ophthalmol. 2002 Nov;86(11):1287-92.

16) Sherwood MB, Smith MF. Prevention of early hypotony associated with Molteno implants by a new occluding stent technique. Ophthalmology. 1993;100(1):85-90.

17)  Deokule SP, Molteno AC, Bevin TH, Herbison P. Long‐term results of Molteno implant insertion in cases of chronic angle closure glaucoma. Clin Experiment Ophthalmol. 2007;35(6):514-9.

18) Shaarawy TM, Sherwood MB, Hitchings R, Crowston JG. Glaucoma: Expert Consult Premium Edition-Enhanced Online Features, Print, and DVD, 2-Volume Set. Elsevier Health Sciences; 2009.

19) Välimäki J. Insertion of sequential glaucoma drainage implant in a piggyback manner. Eye. 2015;29(10):1329-34.

20) Molteno AC, Fucik M, Dempster AG, Bevin TH. Otago Glaucoma Surgery Outcome Study: factors controlling capsule fibrosis around Molteno implants with histopathological correlation. Ophthalmology. 2003 Nov 30;110(11):2198-206.



Molteno® Ophthalmic Limited
PO Box 6322 Dunedin
New Zealand

Phone: +64 3 479 2744
Fax: +64 3 479 2444
Email: sales@molteno.com

site map | privacy statement | about | contact
 

Subscribe

RECEIVE UPDATES
FROM MOLTENO®

site powered by - Turboweb :: Simple Web Manager